3290. Deputy James Lawless asked the Minister for Health the mechanisms that are currently available to allow patients with progressive pulmonary fibrosis to access a drug (details supplied) on an exceptional or compassionate basis pending completion of the reimbursement process; and if she will consider expanding such arrangements for patients with urgent clinical need. [61110/26]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.